院外心脏骤停中静脉与骨内途径肾上腺素给药:一项回顾性队列研究
该回顾性队列研究纳入2011至2015年ROC Cardiac Epistry version 3数据库中因推测心源性原因发生院外心脏骤停、接受EMS心肺复苏并给予肾上腺素的成年患者,按给药途径分为静脉组和骨内组。共纳入35,733例,其中27,758例(77.7%)经静脉给药,7,975例(22.3%)经骨内给药。以骨内组为参照,静脉组院前ROSC、出院存活和良好神经功能结局的校正OR分别为1.367(95%CI 1.276-1.464)、1.468(95%CI 1.264-1.705)和1.849(95%CI 1.526-2.240),倾向性评分匹配人群和亚组分析结果相似。作者认为,在院前复苏的晚期生命支持中,静脉途径似乎是肾上腺素给药的最佳途径。
要点
- 在35,733例院外心脏骤停接受肾上腺素的患者中,静脉途径占77.7%(27,758例),骨内途径占22.3%(7,975例)。
- 以骨内途径为参照,静脉途径与院前ROSC的校正OR为1.367(95%CI 1.276-1.464)。
- 静脉途径与出院存活的校正OR为1.468(95%CI 1.264-1.705),与良好神经功能结局的校正OR为1.849(95%CI 1.526-2.240)。
- 倾向性评分匹配人群和亚组分析结果与主分析相似。
- 作者认为,在院前复苏的晚期生命支持中,静脉途径似乎是肾上腺素给药的最佳途径。
适用人群与场景
- 纳入2011至2015年ROC Cardiac Epistry version 3数据库中因推测心源性原因发生院外心脏骤停、接受EMS心肺复苏并给予肾上腺素的成年患者。
研究设计与关键结果
- 回顾性队列研究,纳入35,733例院外心脏骤停患者,静脉组27,758例(77.7%),骨内组7,975例(22.3%)。
- 以骨内组为参照,静脉组院前ROSC的校正OR为1.367(95%CI 1.276-1.464)。
- 以骨内组为参照,静脉组出院存活的校正OR为1.468(95%CI 1.264-1.705)。
- 以骨内组为参照,静脉组良好神经功能结局的校正OR为1.849(95%CI 1.526-2.240)。
- 倾向性评分匹配人群和亚组分析结果与主分析相似。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在院前复苏的晚期生命支持中,与骨内途径相比,静脉途径似乎是肾上腺素给药的最佳途径。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Adrenaline is an important component in the resuscitation of individuals experiencing out-of-hospital cardiac arrest (OHCA). The 2018 Advanced Cardiac Life Support (ACLS) algorithm gives the option of either intravenous (IV) or intraosseous (IO) routes for adrenaline administration during cardiac arrest. However, the optimal route during prehospital resuscitation remains controversial. This study aims to investigate whether IV and IO routes lead to different outcomes in OHCA patients who received prehospital adrenaline.
METHODS: This retrospective analysis included adult patients with OHCA of presumed cardiac origin who had Emergency Medical Services (EMS) CPR, received adrenaline, and were enrolled in the Resuscitation Outcomes Consortium (ROC) Cardiac Epistry version 3 database between 2011 and 2015. We divided the study population into IV and IO groups based on the administration route. Logistic regression analysis was performed to evaluate the association between adrenaline delivery routes and prehospital return of spontaneous circulation (ROSC), survival to hospital discharge, and favorable neurological outcome.
RESULTS: Of the 35,733 patients included, 27,758 (77.7%) had adrenaline administered via IV access and 7975 (22.3%) via IO access. With the IO group as a reference in the logistic regression model, the adjusted odds ratios of the IV group for prehospital ROSC, survival and favorable neurological outcome were 1.367 (95%CI, 1.276-1.464), 1.468 (95%CI, 1.264-1.705) and 1.849 (95%CI, 1.526-2.240), respectively. Similar results were found in the propensity score matched population and subgroup analysis.
CONCLUSION: Compared with the IO approach, the IV approach appears to be the optimal route for adrenaline administration in advanced life support for OHCA during prehospital resuscitation.
参考来源
- Zhang Y, Zhu J, Liu Z, et al. Intravenous versus intraosseous adrenaline administration in out-of-hospital cardiac arrest: A retrospective cohort study. Resuscitation. 2020. PMID: 31982506. doi:10.1016/j.resuscitation.2020.01.009
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。